Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context
Nicholas Latimer(Institute of Cancer Research), Michael J. Campbell(University of Sheffield), Ron Akehurst(University of Sheffield), Allan Wailoo(University of Sheffield), James P. Morden(Institute of Cancer Research), Paul C. Lambert(Norwegian Institute of Public Health), Michael J. Crowther(Karolinska Institutet), Keith R. Abrams(University of Warwick)
Cited by 105
Related Papers
Analysis of serial measurements in medical research.
|BMJ|1990|3.2k
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
|Pilot and Feasibility Studies|2016|3k
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
|Statistical Methods in Medical Research|2015|2k